PHP
ABSI icon

Parkman Healthcare Partners’s Absci ABSI Stock Holding History

Parkman Healthcare Partners’s Portfolio ABSI Stock Details ABSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.59M Buy
1,864,806
+406,154
+28% +$1.18M 0.58% 51
2025
Q4 		$5.09M Buy
+1,458,652
New +$5.32M 0.48% 64

Other funds holding ABSI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AMD
Advanced Micro Devices Santa Clara, California $174M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Parkman Healthcare Partners's ABSI Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Absci (ABSI) stake by 28% in Q1 2026, buying an estimated $1.18M and bringing the position to 1,864,806 shares worth $5.59M. The position accounts for 0.58% of the portfolio, ranked #51.

Parkman Healthcare Partners first reported a position in ABSI in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold ABSI as of Q1 2026.

  • Parkman Healthcare Partners held 1,864,806 shares of Absci worth $5.59M as of Q1 2026.
  • Parkman Healthcare Partners bought 406,154 Absci shares in Q1 2026, an estimated $1.18M.
  • Absci made up 0.58% of Parkman Healthcare Partners's portfolio in Q1 2026, its #51 holding.
  • Parkman Healthcare Partners first reported a position in Absci in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Absci as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.